Off-label use of novel anticoagulants for treatment of cerebral venous thrombosis: A Canadian survey

Int J Stroke. 2017 Dec;12(9):NP16-NP18. doi: 10.1177/1747493015616643. Epub 2016 Jan 12.

Authors

Thalia S Field¹, Marie-Christine Camden², Sohaila Al-Shimemeri¹, Gary Lui¹, Agnes Yy Lee³

Affiliations

¹ Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
² Division de Neurologie, Department de médecine, Universitaire de Quebec, Quebec City, Canada.
³ Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

PMID: 26763915
DOI: 10.1177/1747493015616643

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use*
Canada
Humans
Intracranial Thrombosis / drug therapy*
Off-Label Use*
Practice Patterns, Physicians'
Specialization
Stroke / drug therapy
Surveys and Questionnaires
Time Factors
Venous Thrombosis / drug therapy*

Substances

Anticoagulants